Insider Transactions in Q1 2022 at Navidea Biopharmaceuticals, Inc. (NAVB)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.5%
|
-
|
|
Mar 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.86%
|
-
|
|
Mar 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
Mar 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.68%
|
-
|
|
Feb 28
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.71%
|
-
|
|
Feb 28
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+5.1%
|
-
|
|
Feb 28
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
Feb 28
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.71%
|
-
|
|
Jan 31
2022
|
Amit Bhalla Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+4.94%
|
-
|
|
Jan 31
2022
|
Alexander L Cappello Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+5.38%
|
-
|
|
Jan 31
2022
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+0.03%
|
-
|
|
Jan 31
2022
|
Malcolm G Witter Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.74%
|
-
|
|
Jan 14
2022
|
Michael Stanley Rosol Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,728
+34.65%
|
-
|